Venus Medtech Hangzhou Inc
HKEX:2500

Watchlist Manager
Venus Medtech Hangzhou Inc Logo
Venus Medtech Hangzhou Inc
HKEX:2500
Watchlist
Price: 2.3 HKD -3.36%
Market Cap: HK$1B

Wall Street
Price Targets

Price Targets Summary
Venus Medtech Hangzhou Inc

There are no price targets for Venus Medtech Hangzhou Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Venus Medtech Hangzhou Inc Competitors:
Price Targets
HZO
MarineMax Inc
22% Upside
CAR
Avis Budget Group Inc
26% Upside
FDMT
4D Molecular Therapeutics Inc
277% Upside

Revenue
Forecast

26% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
26% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

For the last 6 years the compound annual growth rate for Venus Medtech Hangzhou Inc's revenue is 26%. The projected CAGR for the next 3 years is 32%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Venus Medtech Hangzhou Inc's stock price target?
Not Available

Venus Medtech Hangzhou Inc doesn't have any price targets made by Wall Street professionals.

What is Venus Medtech Hangzhou Inc's Revenue forecast?
Projected CAGR
32%

For the last 6 years the compound annual growth rate for Venus Medtech Hangzhou Inc's revenue is 26%. The projected CAGR for the next 3 years is 32%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett